TechnologyNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 1630212ALBT stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $1.6M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

ALBT Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Avalon GloboCare Corp. (ALBT), a Technology sector company. ALBT is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $1.6m in revenue. Based on the latest XBRL financial filings (Q1 2026), Avalon GloboCare Corp. reports net income of $-4.5M, free cash flow of $-2.9M. Top institutional holders of ALBT by reported 13-F value include Equitable Holdings,, GEODE CAPITAL MANAGEMENT,, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ALBT trades on the Nasdaq exchange and files with the SEC under CIK 1630212. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ALBT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Avalon GloboCare Corp. directly from SEC EDGAR.

Net Income

Q1 2026

$-4.5M

Free Cash Flow

Q1 2026

$-2.9M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-62.2% YoY
$1.4MFY 2023
FY20 $1.4MFY21 $1.4MFY22 $3.6MFY23 $1.4M

Net Income

-40.0% YoY
$-16.7MFY 2023
FY20 $-12.7MFY21 $-9.1MFY22 $-11.9MFY23 $-16.7M

Operating Income

-79.2% YoY
$-15.8MFY 2023
FY20 $-12.5MFY21 $-8.8MFY22 $-8.8MFY23 $-15.8M

EPS (Diluted)

-1760.1% YoY
$-1.59FY 2023
FY20 FY21 $-0.01FY22 $-0.09FY23 $-1.59

Total Assets

+4.2% YoY
$20.6MFY 2023
FY20 $10.4MFY21 $10.2MFY22 $19.8MFY23 $20.6M

Total Debt

$1.0MFY 2023
FY20 FY21 $3.0MFY22 FY23 $1.0M

Op. Cash Flow

+7.6% YoY
$-6.5MFY 2023
FY20 $-7.5MFY21 $-5.0MFY22 $-7.0MFY23 $-6.5M

AI Insight: ALBT Financial Trends

ALBT has generated zero revenue across every reported quarter while equity swung from $7M positive to negative and back, signaling deep pre-revenue distress.

Revenue has been $0M in every quarter from Q2 2024 through Q3 2025; no commercial traction is visible in the data.

Equity collapsed from $7M in Q4 2024 to -$7M in Q2 2025, then recovered to $12M by Q1 2026 — highly volatile capital structure.

Net loss spiked to -$13M in Q2 2025 versus a typical -$2M run-rate, suggesting a large one-time charge before reverting to -$4M in Q1 2026.

Operating cash burn has persisted every quarter; with no revenue, sustainability depends entirely on external financing or asset transactions.

The Q2 2025 net loss anomaly (-$13M vs. typical -$2M) is unexplained by operating income alone — underlying charge warrants scrutiny.

Equity recovery to $12M in Q1 2026 despite ongoing losses suggests equity issuance; dilution risk should be monitored closely.

AI Insight: ALBT Ratio Trends

ALBT remains deeply unprofitable across all measurable periods, with ROIC deteriorating to -92.8% in Q1 2026 after a brief improvement to -68.9% in Q4 2024.

ROIC swung from -94.0% in Q3 2024 to -68.9% in Q4 2024, then worsened sharply to -92.8% in Q1 2026.

ROE remains severely negative, moving from -124.4% in Q3 2024 to -152.8% in Q1 2026, indicating persistent equity destruction.

ROA of -11.1% in Q3 2025 was the least negative reading in the dataset, but Q4 2025 ROA deteriorated back to -35.3%.

OpMargin and NPM data are available only for Q3 2025 (-21.8% and -72.6%); pervasive data gaps obscure the true profitability trajectory.

ROA plunged from -11.1% in Q3 2025 to -35.3% in Q4 2025, signaling a sharp asset-utilization deterioration in a single quarter.

Get alerted when ALBT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Avalon GloboCare Corp. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of ALBT

Put ALBT on your watchlist

Track score changes the day Avalon GloboCare Corp. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is ALBT a good stock to buy?

13F Pro's AI-powered analysis of Avalon GloboCare Corp. (ALBT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ALBT are available on the ALBT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own ALBT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ALBT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Avalon GloboCare Corp.'s investment landscape.